Marques, T. M., van Rumund, A., Bruinsma, I. B., Wessels, H. J. C. T., Gloerich, J., Esselink, R. A. J., . . . Verbeek, M. M. (2018). Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls. Mol Neurobiol.
Citação norma ChicagoMarques, Tainá M., Anouke van Rumund, Ilona B. Bruinsma, Hans J. C. T. Wessels, Jolein Gloerich, Rianne A. J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, and Marcel M. Verbeek. "Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients With Parkinsonism From Controls." Mol Neurobiol 2018.
ציטוט MLAMarques, Tainá M., et al. "Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients With Parkinsonism From Controls." Mol Neurobiol 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.